Chronic Obstructive Pulmonary Disease
📧 Sign up to get email alerts when something new happens for Chronic Obstructive Pulmonary Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2016-02-23Clinical Trial Update: Effects of Exhalation Valve on the Lack of Air and Exercise Tolerance in Patients With COPD [NA]
This document provides an update on a clinical trial evaluating an exhalation valve to improve air hunger and exercise tolerance in patients…
-
CLINICAL_TRIALS trial_result · 2016-02-19Clinical Trial Update: A Study To Examine The Safety, Pharmacokinetics And Pharmacodynamics Of PF-03635659 In Patients With Chronic Obstructive Pulmonary Disease [Phase 2]
Pfizer completed a Phase 2 study evaluating the safety, pharmacokinetics, and pharmacodynamics of PF-03635659 in patients with chronic obstr…
-
CLINICAL_TRIALS trial_result · 2016-02-19Clinical Trial Update: Evaluation of Post-operative Respiratory Complications After Thoracic Surgery in Patients With COPD
Clinical trial update describing a completed study evaluating postoperative respiratory complications after thoracic surgery in patients wit…
-
CLINICAL_TRIALS trial_result · 2016-02-19Clinical Trial Update: HDAC Activity in Peripheral Skeletal Muscle in COPD
A completed clinical trial investigating histone deacetylase activity in peripheral skeletal muscle among people with chronic obstructive pu…
-
CLINICAL_TRIALS trial_result · 2016-02-18Clinical Trial Update: Prospective Evaluation of Airways Reactivity
Completed prospective evaluation of airway reactivity sponsored by NHLBI, examining conditions such as asthma and obstructive lung diseases.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA label_change · 2016-02-16FDA Approved: BREO ELLIPTA — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for BREO ELLIPTA submitted by GlaxoSmithKline LLC to update its labeling.
-
CLINICAL_TRIALS trial_result · 2016-02-15Clinical Trial Update: A 12-week Study to Evaluate the Efficacy and Safety of Umeclidinium 62.5 Microgram (mcg) Compared With Glycopyrronium 44 mcg in Subjects With Chronic Obstructive Pulmonary Disease (COPD) [Phase 4]
A Phase 4, 12-week study comparing umeclidinium 62.5 mcg with glycopyrronium 44 mcg in chronic obstructive pulmonary disease to evaluate eff…
-
CLINICAL_TRIALS trial_result · 2016-02-15Clinical Trial Update: Evaluate Safety of Technosphere® Insulin (TI) in Diabetic Subjects With Moderate Obstructive Pulmonary Disease [Phase 3]
Phase 3 safety evaluation of Technosphere insulin in adults with Type 1 or Type 2 diabetes who also have moderate COPD or asthma; the study …
-
CLINICAL_TRIALS trial_result · 2016-02-15Clinical Trial Update: Ventilator Adapters for Combivent Respimat [Phase 4]
A Phase 4 study evaluating ventilator adapters for Boehringer Ingelheim's Combivent Respimat was terminated, with results posted on 2016-02-…
-
CLINICAL_TRIALS trial_result · 2016-02-12Clinical Trial Update: Characterization of Lung Function Profile of Inhaled Tiotropium + Olodaterol Fixed Dose Combination Compared to Fluticasone Propionate + Salmeterol Fixed Dose Combination in COPD Patients [Phase 3]
A Phase 3 head-to-head trial comparing inhaled tiotropium + olodaterol fixed-dose combination to fluticasone propionate + salmeterol fixed-d…
-
CLINICAL_TRIALS trial_result · 2016-02-11Clinical Trial Update: Efficacy of Varenicline on Smoking Cessation at the Acute Phase of an Exacerbation of Chronic Obstructive Pulmonary Disease [Phase 3]
Phase 3 study evaluating varenicline for smoking cessation during the acute phase of COPD exacerbation has completed, reporting on its effic…
-
CLINICAL_TRIALS trial_result · 2016-02-10Clinical Trial Update: Oxis 9mcg Turbuhaler Clinical Experience Investigation
This is a completed clinical trial update evaluating the clinical experience with Oxis 9 mcg Turbuhaler in chronic obstructive pulmonary dis…
-
CLINICAL_TRIALS trial_result · 2016-02-09Clinical Trial Update: Swiss studY for the Treatment of COPD Patients With the Free combiNation of indacatERol and GlYcopyrroniumbromide. [Phase 3]
A Phase 3 trial evaluating the free combination of indacaterol and glycopyrronium bromide for chronic obstructive pulmonary disease has comp…
-
CLINICAL_TRIALS trial_result · 2016-02-09Clinical Trial Update: A 12-week Study to Evaluate the Efficacy and Safety of Umeclidinium Compared With Tiotropium in Subjects With Chronic Obstructive Pulmonary Disease [Phase 3]
Phase 3 trial comparing umeclidinium to tiotropium in chronic obstructive pulmonary disease has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2016-02-08Clinical Trial Update: Detection and Characterization of COPD in Dairy Farmers
A completed clinical trial evaluating detection and characterization of chronic obstructive pulmonary disease in dairy farmers, focusing on …
-
CLINICAL_TRIALS research · 2016-02-08Clinical Trial Update: Telehealth Program in Chronic Patients [NA]
This ClinicalTrials.gov entry reports the completion of a telehealth program study in chronic patients with Chronic Obstructive Pulmonary Di…
-
CLINICAL_TRIALS research · 2016-02-04Clinical Trial Update: Acute Exacerbation of Chronic Obstructive Pulmonary Disease Inpatient Registry Study
This entry reports a clinical trial registry study on acute exacerbations of chronic obstructive pulmonary disease inpatients, sponsored by …
-
CLINICAL_TRIALS trial_result · 2016-02-03Clinical Trial Update: Comparative Effectiveness of Symbicort vs. Advair Among COPD Patients
A completed clinical trial comparing Symbicort (budesonide/formoterol) with Advair (salmeterol/fluticasone) in patients with chronic obstruc…
-
CLINICAL_TRIALS research · 2016-02-03Clinical Trial Update: Biomarker Assay Validation in Healthy Smokers and COPD Smokers and Ex-smokers
This trial update reports on the validation of a biomarker assay in cohorts of healthy smokers, COPD smokers, and COPD ex-smokers. The condi…
-
CLINICAL_TRIALS trial_result · 2016-02-03Clinical Trial Update: Comparative Effectiveness of Symbicort vs. Spiriva Among COPD Patients
A completed comparative effectiveness trial evaluated Symbicort (budesonide/formoterol) versus Spiriva (tiotropium) in patients with chronic…
-
CLINICAL_TRIALS withdrawal · 2016-02-02Clinical Trial Update: TruFreeze™ Airway Obstruction: TAO STUDY [Phase 4]
CSA Medical's TAO Study of TruFreeze for airway obstruction in obstructive lung disease has been withdrawn.
-
FDA label_change · 2016-01-29FDA Approved: COMBIVENT RESPIMAT — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA supplemental approval for Combivent Respimat (ipratropium bromide and albuterol) updates the product labeling following Boehringer Ingel…
-
CLINICAL_TRIALS trial_result · 2016-01-29Clinical Trial Update: Changes in Cytokine Levels During an Acute Exacerbation of Chronic Obstructive Pulmonary Disease
The trial update reports changes in cytokine levels observed during acute exacerbations of chronic obstructive pulmonary disease.
-
CLINICAL_TRIALS trial_result · 2016-01-29Clinical Trial Update: Innate and Adaptive Immunity in Individuals Experiencing Chronic Obstructive Pulmonary Disease Exacerbations
This update reports on a completed clinical trial investigating innate and adaptive immune responses during COPD exacerbations. The study fo…
-
CLINICAL_TRIALS trial_result · 2016-01-28Clinical Trial Update: Is Patients With Pulmonary Disease Benefit a Program With Yogic Exercises? [NA]
ClinicalTrials.gov study NCT02233114 has completed. It investigates whether a yoga-based exercise program benefits patients with COPD or ast…